KEGG   PATHWAY: bacu05017
Entry
bacu05017                   Pathway                                
Name
Spinocerebellar ataxia - Balaenoptera acutorostrata scammoni (minke whale)
Description
The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
Class
Human Diseases; Neurodegenerative disease
Pathway map
bacu05017  Spinocerebellar ataxia
bacu05017

Organism
Balaenoptera acutorostrata scammoni (minke whale) [GN:bacu]
Gene
103018728  TRPC3; transient receptor potential cation channel subfamily C member 3 [KO:K04966]
103018216  GNAQ; G protein subunit alpha q [KO:K04634]
103020805  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
102997432  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
103007077  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
103006361  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
103004532  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
103012542  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
103017540  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
103002398  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]
103017187  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]
103007483  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]
103010644  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
103018280  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102999302  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
103004624  ATXN2L; ataxin 2 like [KO:K23625]
103016284  ATXN2; ataxin 2 [KO:K23625]
103014574  ATXN3; ataxin 3 [KO:K11863] [EC:3.4.22.-]
103007765  RYR1; ryanodine receptor 1 [KO:K04961]
103016914  PDYN; prodynorphin [KO:K15840]
103001022  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
103006151  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
102999259  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
103008767  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
103006149  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
103009886  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
103016685  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]
103007311  MCU; mitochondrial calcium uniporter [KO:K20858]
103017981  VDAC1; voltage dependent anion channel 1 [KO:K05862]
103000396  VDAC2; voltage dependent anion channel 2 [KO:K15040]
103013826  VDAC3; voltage dependent anion channel 3 [KO:K15041]
103012727  voltage-dependent anion-selective channel protein 3-like [KO:K15041]
102999263  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
103012312  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
103009487  SLC25A6; solute carrier family 25 member 6 [KO:K05863]
103012461  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
103015321  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]
103017780  cytochrome c 2-like [KO:K08738]
102999215  cytochrome c-like [KO:K08738]
103004375  cytochrome c-like [KO:K08738]
103003361  cytochrome c-like [KO:K08738]
103001381  AFG3L2; AFG3 like matrix AAA peptidase subunit 2 [KO:K08956] [EC:3.4.24.-]
103015876  OMA1; OMA1 zinc metallopeptidase [KO:K23010] [EC:3.4.24.-]
103019109  OPA1; OPA1, mitochondrial dynamin like GTPase [KO:K17079] [EC:3.6.5.5]
103019647  FGF14; fibroblast growth factor 14 [KO:K23920]
103015074  SPTBN2; spectrin beta, non-erythrocytic 2 [KO:K23932]
103002925  PSMA6; proteasome subunit alpha 6 [KO:K02730] [EC:3.4.25.1]
103009830  PSMA2; proteasome subunit alpha 2 [KO:K02726] [EC:3.4.25.1]
103015447  PSMA4; proteasome subunit alpha 4 [KO:K02728] [EC:3.4.25.1]
103020881  PSMA8; proteasome subunit alpha 8 [KO:K02731] [EC:3.4.25.1]
103011376  PSMA7; proteasome subunit alpha 7 [KO:K02731] [EC:3.4.25.1]
103011116  PSMA5; proteasome subunit alpha 5 [KO:K02729] [EC:3.4.25.1]
103008137  PSMA1; proteasome subunit alpha 1 [KO:K02725] [EC:3.4.25.1]
103017220  proteasome subunit alpha type-3-like [KO:K02727] [EC:3.4.25.1]
102999694  PSMA3; proteasome subunit alpha 3 [KO:K02727] [EC:3.4.25.1]
103008572  PSMB6; proteasome subunit beta 6 [KO:K02738] [EC:3.4.25.1]
102999149  PSMB7; proteasome subunit beta 7 [KO:K02739] [EC:3.4.25.1]
103015195  PSMB3; proteasome subunit beta 3 [KO:K02735] [EC:3.4.25.1]
103016906  PSMB2; proteasome subunit beta 2 [KO:K02734] [EC:3.4.25.1]
103007277  PSMB5; proteasome subunit beta 5 [KO:K02737] [EC:3.4.25.1]
103016536  PSMB1; proteasome subunit beta 1 [KO:K02732] [EC:3.4.25.1]
103019839  PSMB4; proteasome subunit beta 4 [KO:K02736] [EC:3.4.25.1]
103000444  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]
103002114  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]
103006284  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]
103007530  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]
102999378  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]
103018659  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]
103004389  PSMD2; proteasome 26S subunit, non-ATPase 2 [KO:K03028]
103001312  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]
103005534  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]
103009565  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]
102997438  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]
103011786  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]
103010736  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]
103012664  26S proteasome non-ATPase regulatory subunit 7-like [KO:K03038]
103011407  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]
103016891  PSMD4; proteasome 26S subunit, non-ATPase 4 [KO:K03029]
103012608  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]
103020692  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]
102998266  ADRM1; adhesion regulating molecule 1 [KO:K06691]
103016780  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
103013880  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
102999328  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
102997603  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
103007019  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
103008728  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
103019478  ATXN1; ataxin 1 [KO:K23616]
103020179  KAT5; lysine acetyltransferase 5 [KO:K11304] [EC:2.3.1.48]
103012995  RORA; RAR related orphan receptor A [KO:K08532]
103008249  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]
102997251  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]
102998569  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
103000803  SLC1A6; solute carrier family 1 member 6 [KO:K05617]
103008580  CIC; capicua transcriptional repressor [KO:K20225]
103016274  protein capicua homolog [KO:K20225]
103010627  PUM1; pumilio RNA binding family member 1 [KO:K17943]
103010972  PUM2; pumilio RNA binding family member 2 [KO:K17943]
103014400  TBP; TATA-box binding protein [KO:K03120]
103015815  TBPL1; TATA-box binding protein like 1 [KO:K03120]
102998040  TBPL2; TATA-box binding protein like 2 [KO:K03120]
103006356  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]
103010578  SP1; Sp1 transcription factor [KO:K04684]
103003104  GTF2B; general transcription factor IIB [KO:K03124]
103013994  NFYA; nuclear transcription factor Y subunit alpha [KO:K08064]
103006856  MYOD1; myogenic differentiation 1 [KO:K09064]
103004460  MTOR; mechanistic target of rapamycin [KO:K07203] [EC:2.7.11.1]
103000929  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]
103000249  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]
102997694  ATG101; autophagy related 101 [KO:K19730]
103011941  ATG13; autophagy related 13 [KO:K08331]
103007012  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]
103009999  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]
103019765  beclin-2-like [KO:K08334]
102999262  beclin-1-like [KO:K08334]
103012872  beclin-1-like [KO:K08334]
102999939  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]
103015639  ATG14; autophagy related 14 [KO:K17889]
103018902  NRBF2; nuclear receptor binding factor 2 [KO:K21246]
103003736  PIK3C3; phosphatidylinositol 3-kinase, catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]
102998218  ATG2A; autophagy related 2A [KO:K17906]
103018936  ATG2B; autophagy related 2B [KO:K17906]
103001233  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]
103008082  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]
103001204  KCNC3; potassium voltage-gated channel subfamily C member 3 [KO:K04889]
103016646  KCND3; potassium voltage-gated channel subfamily D member 3 [KO:K04893]
102999363  RELN; reelin [KO:K06249] [EC:3.4.21.-]
103021070  VLDLR; very low density lipoprotein receptor [KO:K20053]
103016915  DAB1; DAB1, reelin adaptor protein [KO:K20054]
103012691  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
103012931  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
103014043  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
103008077  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
103009307  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
103007464  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
103002026  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
103013147  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
103004139  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
103006521  TWNK; twinkle mtDNA helicase [KO:K17680] [EC:5.6.2.3]
102999034  ATXN10; ataxin 10 [KO:K19323]
103016979  BEAN1; brain expressed, associated with NEDD4, 1 [KO:K19324]
102998975  NOP56; NOP56 ribonucleoprotein [KO:K14564]
Compound
C00025  L-Glutamate
C00076  Calcium cation
C00165  Diacylglycerol
C00238  Potassium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
Reference
  Authors
Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  Title
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  Journal
Cerebellum 9:148-66 (2010)
DOI:10.1007/s12311-009-0144-2
Reference
  Authors
Duenas AM, Goold R, Giunti P
  Title
Molecular pathogenesis of spinocerebellar ataxias.
  Journal
Brain 129:1357-70 (2006)
DOI:10.1093/brain/awl081
Reference
  Authors
Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  Title
Keeping Our Calcium in Balance to Maintain Our Balance.
  Journal
Biochem Biophys Res Commun 483:1040-1050 (2017)
DOI:10.1016/j.bbrc.2016.07.020
Reference
  Authors
Egorova PA, Bezprozvanny IB
  Title
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  Journal
FEBS J 285:3547-3565 (2018)
DOI:10.1111/febs.14366
Reference
  Authors
Shimobayashi E, Kapfhammer JP
  Title
Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  Journal
Curr Neuropharmacol 16:151-159 (2018)
DOI:10.2174/1570159X15666170529104000
Reference
  Authors
Kasumu A, Bezprozvanny I
  Title
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  Journal
Cerebellum 11:630-9 (2012)
DOI:10.1007/s12311-010-0182-9
Reference
  Authors
Egorova P, Popugaeva E, Bezprozvanny I
  Title
Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  Journal
Semin Cell Dev Biol 40:127-33 (2015)
DOI:10.1016/j.semcdb.2015.03.010
Reference
  Authors
Hisatsune C, Hamada K, Mikoshiba K
  Title
Ca(2+) signaling and spinocerebellar ataxia.
  Journal
Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
DOI:10.1016/j.bbamcr.2018.05.009
Reference
  Authors
Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  Title
Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  Journal
Mol Neurobiol 54:6870-6884 (2017)
DOI:10.1007/s12035-016-0205-8
Reference
  Authors
Brown SA, Loew LM
  Title
Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  Journal
Front Neurosci 8:453 (2014)
DOI:10.3389/fnins.2014.00453
Reference
  Authors
Inoue T
  Title
Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  Journal
Keio J Med 52:244-9 (2003)
DOI:10.2302/kjm.52.244
Reference
  Authors
Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  Title
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  Journal
J Biol Chem 283:19854-63 (2008)
DOI:10.1074/jbc.M801492200
Reference
  Authors
Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  Title
Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  Journal
Brain 138:2537-52 (2015)
DOI:10.1093/brain/awv195
Reference
  Authors
Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  Title
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  Journal
J Med Genet 56:499-511 (2019)
DOI:10.1136/jmedgenet-2018-105766
Reference
  Authors
Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  Title
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  Journal
Neurobiol Dis 124:14-28 (2019)
DOI:10.1016/j.nbd.2018.10.018
Reference
  Authors
Becker EBE
  Title
From Mice to Men: TRPC3 in Cerebellar Ataxia.
  Journal
Cerebellum 16:877-879 (2017)
DOI:10.1007/s12311-015-0663-y
Reference
  Authors
Hoxha E, Tempia F, Lippiello P, Miniaci MC
  Title
Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  Journal
Front Synaptic Neurosci 8:35 (2016)
DOI:10.3389/fnsyn.2016.00035
Reference
  Authors
Yan H, Pablo JL, Pitt GS
  Title
FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  Journal
Cell Rep 4:66-75 (2013)
DOI:10.1016/j.celrep.2013.06.012
Reference
  Authors
Tada M, Nishizawa M, Onodera O
  Title
Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  Journal
Neurochem Int 94:1-8 (2016)
DOI:10.1016/j.neuint.2016.01.007
Reference
  Authors
Pietrobon D
  Title
CaV2.1 channelopathies.
  Journal
Pflugers Arch 460:375-93 (2010)
DOI:10.1007/s00424-010-0802-8
Reference
  Authors
Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  Title
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  Journal
Neurobiol Dis 17:198-204 (2004)
DOI:10.1016/j.nbd.2004.07.013
Reference
  Authors
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  Title
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  Journal
Genes Dev 16:1345-55 (2002)
DOI:10.1101/gad.992302
Reference
  Authors
Evers MM, Toonen LJ, van Roon-Mom WM
  Title
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  Journal
Mol Neurobiol 49:1513-31 (2014)
DOI:10.1007/s12035-013-8596-2
Reference
  Authors
Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  Title
Polyglutamine tracts regulate autophagy.
  Journal
Autophagy 13:1613-1614 (2017)
DOI:10.1080/15548627.2017.1336278
Reference
  Authors
Chen RH, Chen YH, Huang TY
  Title
Ubiquitin-mediated regulation of autophagy.
  Journal
J Biomed Sci 26:80 (2019)
DOI:10.1186/s12929-019-0569-y
Reference
  Authors
Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  Title
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  Journal
Cell 127:697-708 (2006)
DOI:10.1016/j.cell.2006.09.036
Reference
  Authors
Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  Title
ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  Journal
Neuron 97:1235-1243.e5 (2018)
DOI:10.1016/j.neuron.2018.02.013
Reference
  Authors
Jimenez G, Shvartsman SY, Paroush Z
  Title
The Capicua repressor--a general sensor of RTK signaling in development and disease.
  Journal
J Cell Sci 125:1383-91 (2012)
DOI:10.1242/jcs.092965
Reference
  Authors
Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  Title
A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  Journal
Cell 172:924-936.e11 (2018)
DOI:10.1016/j.cell.2018.02.006
Reference
  Authors
Irie T, Matsuzaki Y, Sekino Y, Hirai H
  Title
Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  Journal
J Physiol 592:229-47 (2014)
DOI:10.1113/jphysiol.2013.264309
Reference
  Authors
Bushart DD, Murphy GG, Shakkottai VG
  Title
Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  Journal
Ann Transl Med 4:25 (2016)
DOI:10.3978/j.issn.2305-5839.2016.01.06
Reference
  Authors
Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  Title
Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  Journal
Hum Mutat 40:2088-2107 (2019)
DOI:10.1002/humu.23865
Reference
  Authors
Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  Title
Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  Journal
Cell Mol Life Sci 72:3387-99 (2015)
DOI:10.1007/s00018-015-1894-2
Reference
  Authors
Matilla-Duenas A, Volpini V
  Title
Spinocerebellar Ataxia Type 37
  Journal
GeneReviews (1993)
Reference
  Authors
Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  Title
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  Journal
Brain 141:1981-1997 (2018)
DOI:10.1093/brain/awy137
Reference
  Authors
Swinnen B, Robberecht W, Van Den Bosch L
  Title
RNA toxicity in non-coding repeat expansion disorders.
  Journal
EMBO J e101112 (2019)
DOI:10.15252/embj.2018101112
Reference
  Authors
Ishikawa K, Nagai Y
  Title
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  Journal
Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
DOI:10.1007/s13311-019-00804-6
Reference
  Authors
Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  Title
Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  Journal
Neuropathology 33:600-11 (2013)
DOI:10.1111/neup.12032
Reference
  Authors
Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  Title
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  Journal
Am J Hum Genet 89:121-30 (2011)
DOI:10.1016/j.ajhg.2011.05.015
Related
pathway
bacu03050  Proteasome
bacu04020  Calcium signaling pathway
bacu04140  Autophagy - animal
bacu04141  Protein processing in endoplasmic reticulum
bacu04210  Apoptosis
bacu04724  Glutamatergic synapse
bacu04730  Long-term depression
KO pathway
ko05017   
LinkDB

DBGET integrated database retrieval system